Skip to content
Shuttingdown

Citius Pharmaceuticals, Inc.

Pharmaceutical Preparations · CRANFORD · NJ

Distress signal

Moderate confidence (50%)

Updated Oct 7, 2026, 12:05 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Citius Pharmaceuticals, Inc. received a delisting notice from its exchange (Aug 17, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Citius Pharmaceuticals, Inc. received a delisting notice from its exchange

    Aug 17, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 17, 2026, Citius Pharmaceuticals, Inc. (the Company ) received formal notice that the Nasdaq Stock Market LLC ( Nasdaq ) granted our request for an extension through February 8, 2027 (the Extension Notice ) to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). If at any time before February 8, 2027, the bid price of our common stock closes at $1.00 per…”
  2. Citius Pharmaceuticals, Inc. received a delisting notice from its exchange

    Feb 9, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On February 9, 2026, Nasdaq Stock Market LLC ( Nasdaq ) notified the Company that for the last 30 consecutive business days, the bid price for the Company s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker CTXR on Nasdaq.
SEC CIK
0001506251
Website
—
LinkedIn
—
Headquarters
CRANFORD, NJ
Also known as
Trail One, Inc., TrailOne, Inc.
Legal entities
Citius Pharmaceuticals, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Citius Pharmaceuticals, Inc. — Pharmaceutical Preparations (SIC 2834) — CRANFORD, NJ
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On February 9, 2026, Nasdaq Stock Market LLC ( Nasdaq ) notified the Company that for the last 30 consecutive business days, the bid price for the Company s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until August 10, 2026, to…
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 17, 2026, Citius Pharmaceuticals, Inc. (the Company ) received formal notice that the Nasdaq Stock Market LLC ( Nasdaq ) granted our request for an extension through February 8, 2027 (the Extension Notice ) to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ). If at any time before February 8, 2027, the bid price of our common stock closes at $1.00 per…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 12:09 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.